| PCMA comments on 2021 Physican Fee Schedule - October 2, 2020.pdf | |
| PCMA comments on NBPP 2022 proposed rule December 28, 2020.pdf | |
| PCMA comments on COVID regulatory relief RFI December 26, 2020.pdf | |
| PCMA comments on HHS SUNSET proposed rule - December 4, 2020.pdf | |
| PCMA Questions for FDA and CMS Regarding Personal Importation - December 3, 2020.pdf | |
| PCMA comments on CY 2022 Advance Notice Part 2 - November 30, 2020.pdf | |
| PCMA comments on CMS Medicare Coverage of Innovative Technology - November 2, 2020.pdf | |
| PCMA comments on 30-day notice - CMS 10725 - October 13, 2020.pdf | |
| PCMA comments on EPCS RFI - October 2, 2020.pdf | |
| PCMA comments on Proposed Rebate Rule - August 3, 2020.pdf | |
| PCMA Good Guidance Practices Comments - September 16 2020.pdf | |
| PCMA comments on CMS VBP and Medicaid Drug Rebate Proposed - July 17, 2020.pdf | |
| PCMA Comments on CMS-5531-IFC - July 1, 2020.pdf | |
| PCMA comments on CMS notice - Agency Information Collection Activities Submission for OMB Review - Document Number 10717- June 30, 2020.pdf | |
| PCMA comments on Policy and Regulatory Revisions in Response to the COVID–19 Public Health Emergency - CMS-1744-IFC.pdf | |
| PCMA 2021 NPRM Comments - April 6, 2020.pdf | |
| PCMA Comments on CMS10725 - Pharmacy Benefit Manager Transparency for QHPs- March 30, 2020.pdf | |
| PCMA Comments on the 2021 Advance Notice Part II - March 6, 2020.pdf | |
| PCMA Comments on NBPP 2021 - March 2, 2020.pdf | |
| PCMA Comments on Importation of Certain FDA-Approved Human Prescription Drugs - March 2, 2020.pdf | |
| PCMA Comments on FDA Draft Guidance - February 20, 2020.pdf | |
| PCMA Comments on Transparency in Coverage Proposed Rule - January 29, 2020.pdf | |
